Company intelligence / Profile preview

Elucid Labs

Waterloo, Ontario, Canadaelucidlabs.com ↗

Ownership: Private
Development stage: Other

Overview

Elucid Labs has developed a portable, non-invasive imaging device that uses artificial intelligence to analyze skin lesions for signs of skin cancer. The technology aims to reduce unnecessary biopsies by providing fast, accurate diagnostic support to dermatologists. The company spun out from academic research at the University of Waterloo and was recognized among Canada’s most innovative tech companies in 2017. As of the latest reports, their product is still under development or early deployment with no large-scale clinical trial results published yet

Therapeutic areas: Oncology
Modalities: DeviceArtificial intelligence-based diagnostic technology
Industry: Medical Imaging

Partnerships

Academic collaborations with University of Waterloo researchers/faculty

Beyond the preview

Go deeper on Elucid Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elucid Labs.

Explore the full profile